Cargando…
Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting
Cancer cachexia is a highly debilitating paraneoplastic disease observed in more than 50% of patients with advanced cancers and directly contributes to 20% of cancer deaths. Loss of skeletal muscle is a defining characteristic of patients with cancer cachexia and is associated with poor survival. Th...
Autores principales: | Shum, Angie M. Y., Mahendradatta, Theodore, Taylor, Ryland J., Painter, Arran B., Moore, Melissa M., Tsoli, Maria, Tan, Timothy C., Clarke, Stephen J., Robertson, Graham R., Polly, Patsie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314175/ https://www.ncbi.nlm.nih.gov/pubmed/22361433 |
Ejemplares similares
-
Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
por: Shum, Angie M. Y., et al.
Publicado: (2018) -
Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation
por: Tsoli, Maria, et al.
Publicado: (2014) -
The role of vitamin D in skeletal and cardiac muscle function
por: Polly, Patsie, et al.
Publicado: (2014) -
G9a inhibits MEF2C activity to control sarcomere assembly
por: Ow, Jin Rong, et al.
Publicado: (2016) -
Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes
Publicado: (1995)